Vaccination of mice with a combination of BCG and killed Leishmania promastigotes reduces acute Trypanosoma cruzi infection by promoting an IFN- γ response

Vaccine

Volumn 17, Issue 7-8, 1999, Pages 957-964

  Araujo, Zaïda ^a   Bouhdidi, Ayachi El ^a   Heremans, Hubertine ^b   Van Marck, Eric ^c   Castés, Marianella ^d   Carlier, Yves ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

^c UNIVERSITY OF ANTWERP   (Belgium)

^d UNIVERSIDAD CENTRAL DE VENEZUELA   (Venezuela)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; GAMMA INTERFERON; PROTOZOAL VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; LEISHMANIA; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMASTIGOTE; TRYPANOSOMA CRUZI; TRYPANOSOMIASIS; VACCINATION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, PROTOZOAN; ANTIBODY SPECIFICITY; BCG VACCINE; CHAGAS DISEASE; INTERFERON TYPE II; LEISHMANIA MEXICANA; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED BALB C; PARASITEMIA; PROTOZOAN VACCINES; SPLEEN; SURVIVAL ANALYSIS; T-LYMPHOCYTES; TRYPANOSOMA CRUZI; VACCINES, COMBINED; VACCINES, INACTIVATED;

EID: 0033605212     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(98)00311-9     Document Type: Article

References (50)

1. Convit J., Castellanos P.L., Rondon A., Pinardi M.E., Ulrich M., Castes M., Bloom B.R., Garcia L. Immunotherapy versus chemotherapy in localized cutaneous leishmaniasis. Lancet. 1:1987;401-405.
2. Convit J., Castellanos P.L., Ulrich M., Castes M., Rondon A., Pinardi M.E., Rodriguez N., Bloom B.R., Formica S., Valecillos L., Bretana A. Immunotherapy of localised, intermediate and diffuse forms of American cutaneous leishmaniasis. J Infec Dis. 160:1989;104-115.
3. Castes M., Moros Z., Martinez A., Trujiillo D., Castellanos P.L., Rondon A.J., Convit J. Cell-mediated immunity in localised cutaneous leishmaniasis patients before and after treatment with immunotherapy or chemotherapy. Paras Immunol. 11:1989;211-222.
4. Castes M., Blackwell J., Trujillo D., Formica S., Cabrera M., Zorrilla G., Rodas A., Castellanos P.L., Convit J. Immune response in healthy volunteers vaccinated with killed leishmanial promastigotes plus BCG. I: Skin-test reactivity, T-cell proliferation and interferon-γ production. Vaccine. 12:1994;1041-1051.
5. Sharples C.E., Shaw M-A., Castes M., Convit J., Blackwell J.M. Immune response in healthy volunteers vaccinated with BCG plus killed leishmanial promastigotes: antibody responses to mycobacterial and leishmanial antigens. Vaccine. 12:1994;1402-1412.
6. Carlier Y., Breniere F.S., Lemesre J.L., Carrasco R., Desjeux P., Afchain D. The interest of immunoprecipitation tests in the immunological diagnosis of Chagas' disease. Ann Soc Bel Med Trop. 65:1985;85-94.
7. Araujo F.G. Analysis of Trypanosoma cruzi antigens bound by specific antibodies and by antibodies to related trypanosomatids. Infect Immun. 53:1986;179-185.
8. Chiller T.M., Samudio M.A., Zoulek G. IgG antibody reactivity with Trypanosoma cruzi and Leishmania antigens in sera of patients with Chagas' disease and leishmaniasis. Am J Trop Med Hyg. 43:1990;650-656.
9. Nafziger D.A., Recinos R.F., Hunter C.A., Donelson J.E. Patients infected with Leishmania donovani chagasi can have antibodies that recognize heat shock and acidic ribosomal proteins of Trypanosoma cruzi. Mol Biochem Parasitol. 49:1991;325-328.
10. Levy-Yeyati P., Bonnefoy S., Mirkin G., Debrabant A., Lafon S., Panebra A., Gonzalez-Cappa E., Dedet J.P., Hontebeyrie-Joskowicz M., Levin M.J. The 70-kDa heat-shock protein is a major antigenic determinant in human Trypanosoma cruzi/Leishmania braziliensis braziliensis mixed infection. Immunol Lett. 31:1992;27-33.
11. Malchiodi E.L., Chiaramonte M.G., Taranto N.J., Zwirner N.W., Margni R.A. Cross reactivity studies and differential serodiagnosis of human infections caused by Trypanosoma cruzi and Leishmania spp; use of immunoblotting and ELISA with a purified antigen (Ag 163B6). Clin Exp Immunol. 97:1994;417-423.
12. Carvalho E.M., Reed S.G., Johnson W.D. Cross reactivity between Trypanosoma cruzi and Leishmania antigens in the lymphocyte blastogenesis assay. Trans Roy Soc Trop Med Hyg. 81:1987;82-84.
13. Reed S.G., Carvalho E.M., Sherbert C.H., Sampaio D.P., Russo D.M., Bacelar O., Pihl D.L., Scott J.M., Barrai A., Grabstein K.H., Johnson W.D. In vitro responses to leishmania antigens by lymphocytes from patients with leishmaniasis or Chagas' disease. J Clin Invest. 85:1990;690-696.
14. Ortiz-Ortiz L., Gonzales-Mendoza A., Lamoyi E. A vaccination procedure against Trypanosoma cruzi infection in mice by nonspecific immunization. J Immunol. 114:1975;1424-1425.
15. Kierszenbaum F., Ferraresi R.W. Enhancement of host resistance against Trypanosoma cruzi infection by the immunoregulatory agent muramyl dipeptide. Infect Immun. 25:1979;273-278.
16. Bertelli M.S.M., Alcantara A., Brener Z. BCG-induced resistance in Trypanosoma cruzi experimental infections. Tropenmed Parasitol. 32:1981;93-96.
17. Umekita L.F., Mota I. Role of the mononuclear phagocytic system in the immune and nonspecific clearance of Trypanosoma cruzi bloodstream trypomastigotes. Br J Med Biol Res. 22:1989;1489-1495.
18. Tanowitz H.B., Amole B., Herman R., Wittner M. Protection against fatal murine Chagas' disease with a Leishmania brasiliensis panamensis stock. Am J Trop Med Hyg. 35:1986;937-941.
19. Pung O.J., Hulsebos L.H., Kuhn R.E. Experimental American leishmaniasis and Chagas' disease in the Brazilian squirrel monkey: cross immunity and electrocardiographic studies of monkeys infected with Leishmania braziliensis and Trypanosoma cruzi. Int J Parasitol. 18:1988;1053-1059.
20. Eisen H., Khan S. Mimicry in Trypanosoma cruzi: fantasy and reality. Curr Opin Immunol. 3:1991;507-510.
21. Van Voorhis W.C., Barrett L., Koelling R., Farr A.G. FL-160 proteins of Trypanosoma cruzi are expressed from a multigene family and contain two distinct epitopes that mimic nervous tissues. J Exp Med. 178:1993;681-694.
22. Ferrari I., Levin M.J., Wallukat G., Elies R., Lebesque D., Chiale P., Elizari M., Rosenbaum M., Hobeke J. Molecular mimicry between the immunodominant ribosomal protein P0 of Trypanosoma cruzi and a functional epitope on the human beta 1-adrenergic receptor. J Exp Med. 182:1995;59-65.
23. Skamene E. Genetic regulation of resistance to mycobacterial infection. Current Topics Microbiol Immunol. 124:1986;49-66.
24. El Bouhdidi A., Truyens C., Rivera M.T., Bazin H., Carlier Y. Trypanosoma cruzi infection in mice induces a polyisotypic hypergammaglobulinaemia and parasite-specific response involving high IgG2a concentrations and highly avid IgG1 antibodies. Parasite Immunol. 16:1994;69-76.
25. Heremans H., Dijkmans R., Sobis H., Vandekerkhove F., Billiau A. Regulation by interferons of the local inflammatory response to bacterial lipopolysaccharide. J Immunol. 138:1987;4175.
26. Carlier Y., Rivera M.T., Truyens C., Puissant F., Milaire J. Interactions between chronic murine Trypanosoma cruzi infection and pregnancy: foetal growth retardation. Am J Trop Med. 37:1987;534-540.
27. Marques de Araujo S., Rivera M.T., El Bouhdidi A., De Maertelaer V., Carlier Y. Maternal Trypanosoma cruzi-specific antibodies and worsening of acute infection in mouse offspring. Am J Trop Med Hyg. 54:1996;13-17.
28. Torrico F., Heremans H., Rivera M.T., Van Marck E., Billiau A., Carlier Y. Endogenous IFN-γ is required for resistance to acute Trypanosoma cruzi infection in mice. J Immunol. 146:1991;3626-3632.
29. Goncalves da Costa S.C., Santos E.B., Lagrange Ph. Vaccination of mice against Leishmania mexicana amazonensis with microsomal fraction associated with BCG. Ann Inst Pasteur Immunol (Paris). 139:1988;143-156.
30. Connell N.D., Medina-Acosta E., McMaster W.R., Bloom B.R., Russell D.G. Effective immunization against cutaneous leishmaniasis with recombinant bacille Calmette-Guerin expressing the leishmania surface proteinase gp63. Proc Natl Acad Sci USA. 90:1993;11473-11477.
31. Abdelhak S., Louzir H., Timm J., Biel L., Benlasfar Z., Lagranderie M., Gheorghui M., Dellagi K., Gicquel B. Recombinant BCG expressing the leihsmania surface antigen Gp63 induces protective immunity against Leishmania major infection in BALB/c mice. Microbiology. 141:1995;1585-1592.
32. Hoff R. Killing in vitro of Trypanosoma cruzi by macrophages from mice immunized with T. cruzi or BCG, and absence of cross-immunity on challenge in vivo. J Exp Med. 142:1975;299-311.
33. Kuhn R.E., Vaughn R.T., Herbst G.A. The effect of BCG on the course of experimental Chagas' disease in mice. Int J Parasitol. 5:1975;557-560.
34. Burgess D.E., Hanson W.L. Heterologous and specific immunization of mice against Trypanosoma cruzi. J Parasitol. 66:1980;340-342.
35. Goncalves da Costa S.C., Lagrange P.H. Development of cell mediated immunity to flagellar antigens and acquired resistance to infection by Trypanosoma cruzi in mice. Mem Inst Oswaldo Cruz (Rio de Janeiro). 76:1981;367-381.
36. Zuñiga C., Palau T., Penin P., Gamallo C., de Diego J.A. Protective effect of Trypanosoma rangeli against infections with a highly virulent strain of Trypanosoma cruzi. Trop Med Int Health. 2:1997;482-487.
37. Bogdan C., Schröppel K., Lohoff M., Röllinghoff M., Solbach W. Immunization of susceptible hosts with a soluble antigen fraction from Leishmania major leads to aggravation of murine leishmaniasis mediated by CD4+ T cells. Eur J Immunol. 20:1990;2533-2540.
38. Vidal S., Tremblay M.L., Govoni G., Gauthier S., Sebastiani G., Malo D., Skamene E., Olivier M., Jothy S., Gros P. The Ity/Lsh/Bcg locus: natural resistance to infection with intracellular parasites is abrogated by disruption of the Nramp1 gene. J Exp Med. 182:1995;655-666.
39. Kawamura I., Yang J., Takaesu Y., Fujita M., Nomoto K., Mitsuyama M. Antigen provoking gamma interferon production in response to Mycobacterium bovis BCG and functional difference in T-cell responses to this antigen between viable and killed BCG-immunized mice. Infect Immun. 62:1994;4396-4403.
40. Huygen K., Lozes E., Gilles B., Drowart A., Palfliet K., Jurion F., Roland I., Art M., Dufaux M., Nyabenda J., et al. Mapping of TH1 helper T-cell epitopes on major secreted mycobacterial antigen 85A in mice infected with live Mycobacterium bovis BCG. Infect Immun. 62:1994;363-370.
41. Harel-Bellan A., Joskowicz M., Fradelizi D., Eisen P. T-lymphocyte function during experimental Chagas' disease: production of and response to interleukin-2. Eur J Immunol. 15:1985;438-442.
42. Tarleton R. Trypanosoma cruzi-induced suppression of IL-2-producing cells. J Immunol. 140:1988;2763-2768.
43. Vandekerckhove F., Darji A., Rivera M.T., Carlier Y., Vray B., Billiau A., De Baetselier P. Modulation of T-cell responsiveness during Trypanosoma cruzi infection: analysis in different lymphoid compartments. Paras Immunol. 16:1994;77-85.
44. Nabors G., Tarleton R. Differential control of IFN-gamma and IL-2 production during Trypanosoma cruzi infection. J Immunol. 146:1991;3591-3598.
45. Zhang L., Tarleton R.L. Characterization of cytokine production in murine Trypanosoma cruzi infection by in situ immunocytochemistry: lack of association between susceptibility and type 2 cytokine production. Eur J Immunol. 26:1996;102-109.
46. Holscher C., Kohler G., Muller U., Mossmann H., Schaub G.A., Brombacher F. Defective nitric oxide effector functions lead to extreme susceptibility of Trypanosoma cruzi-infected mice deficient in gamma interferon receptor or inducible nitric oxide synthase. Infect Immun. 66:1998;1208-1215.
47. Botasso O.A., Ingledew N., Keni M., Morini J., Pividori J.F., Rook G.A.W., Stanford J.L. Cellular immune response to common mycobacterial antigens in subjects seropositive for Trypanosoma cruzi. Lancet. 344:1994;1540-1541.
48. Lussow A.R., Barrios C., Van Embden J., Van der Zee R., Verdini A.S., Pessi A., Louis J.A., Lambert P.H., Del Giudice G. Mycobacterial heat-shock proteins as carrier molecules. Eur J Immunol. 21:1991;2297-2302.
49. Abrahamsohn I.A., Coffman R.L. Cytokine and nitric oxide regulation of the immunosuppression in Trypanosoma cruzi infection. J Immunol. 155:1995;3955-3963.
50. Liew F.Y., O'Donnell C.A. Immunology of leishmaniasis. Adv Parasitol. 32:1993;161-259.